Anthem Inc (NYSE:ANTM) Shares Acquired by Triodos Investment Management BV

Triodos Investment Management BV grew its holdings in Anthem Inc (NYSE:ANTM) by 9.5% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 101,590 shares of the company’s stock after buying an additional 8,840 shares during the period. Anthem accounts for about 6.2% of Triodos Investment Management BV’s holdings, making the stock its 3rd biggest holding. Triodos Investment Management BV’s holdings in Anthem were worth $24,392,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of ANTM. Cox Capital Mgt LLC lifted its holdings in Anthem by 3.1% during the 2nd quarter. Cox Capital Mgt LLC now owns 2,424 shares of the company’s stock valued at $684,000 after buying an additional 74 shares in the last quarter. Pensionfund DSM Netherlands raised its position in shares of Anthem by 14.3% during the second quarter. Pensionfund DSM Netherlands now owns 11,425 shares of the company’s stock worth $3,224,000 after acquiring an additional 1,425 shares during the last quarter. Pensionfund Sabic raised its position in shares of Anthem by 9.3% during the second quarter. Pensionfund Sabic now owns 7,650 shares of the company’s stock worth $2,159,000 after acquiring an additional 650 shares during the last quarter. Fulton Bank N.A. raised its position in shares of Anthem by 9.3% during the second quarter. Fulton Bank N.A. now owns 8,337 shares of the company’s stock worth $2,353,000 after acquiring an additional 710 shares during the last quarter. Finally, Silverleafe Capital Partners LLC bought a new stake in shares of Anthem during the second quarter worth $2,509,000. Institutional investors and hedge funds own 89.09% of the company’s stock.

In related news, EVP Peter D. Haytaian sold 9,586 shares of Anthem stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $269.57, for a total transaction of $2,584,098.02. Following the completion of the sale, the executive vice president now owns 42,488 shares in the company, valued at approximately $11,453,490.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.17% of the company’s stock.

NYSE ANTM traded up $2.32 on Friday, reaching $282.09. The company had a trading volume of 1,213,272 shares, compared to its average volume of 1,697,421. Anthem Inc has a 12 month low of $227.16 and a 12 month high of $317.99. The stock has a market capitalization of $69.22 billion, a PE ratio of 17.75, a price-to-earnings-growth ratio of 1.01 and a beta of 0.74. The firm’s 50 day moving average price is $252.84 and its 200 day moving average price is $270.42. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 0.60.

Anthem (NYSE:ANTM) last issued its quarterly earnings data on Wednesday, October 23rd. The company reported $4.87 EPS for the quarter, topping analysts’ consensus estimates of $4.82 by $0.05. Anthem had a net margin of 4.29% and a return on equity of 15.59%. The business had revenue of $26.44 billion during the quarter, compared to analysts’ expectations of $25.88 billion. During the same period last year, the company posted $3.81 EPS. The business’s revenue was up 15.1% on a year-over-year basis. On average, research analysts expect that Anthem Inc will post 19.43 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Thursday, December 5th will be issued a dividend of $0.80 per share. The ex-dividend date is Wednesday, December 4th. This represents a $3.20 dividend on an annualized basis and a yield of 1.13%. Anthem’s payout ratio is 20.14%.

ANTM has been the subject of a number of recent research reports. Wells Fargo & Co restated a “buy” rating on shares of Anthem in a research report on Friday, July 26th. ValuEngine cut Anthem from a “hold” rating to a “sell” rating in a research note on Friday, November 1st. Mizuho initiated coverage on Anthem in a research note on Thursday, October 17th. They issued a “neutral” rating and a $262.00 target price for the company. Morgan Stanley upped their price objective on Anthem from $356.00 to $360.00 and gave the stock an “overweight” rating in a research report on Thursday, October 24th. Finally, Credit Suisse Group reduced their price objective on Anthem from $345.00 to $340.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and thirteen have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $319.72.

About Anthem

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.

Featured Article: What causes a stock to be most active?

Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem Inc (NYSE:ANTM).

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.